相关实验视频
Updated: Jun 20, 2026

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
孔隙空洞Fe(3) O(4) 纳米颗粒用于青的向输送和受控释放
Kai Cheng1, Sheng Peng, Chenjie Xu
1Department of Chemistry, Brown University, Providence, Rhode Island 02912, USA.
Journal of the American Chemical Society
|September 3, 2009
概括
我们开发了新的氧化铁纳米颗粒,用于控制的西斯输送. 这些多孔空洞纳米粒子 (PHNP) 在酸性瘤环境中更快地释放药物,增强向癌症治疗.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 西斯是一种关键的化疗药物,但在向输送和副作用方面存在局限性.
- 开发先进的药物输送系统对于提高西斯的治疗疗效和降低毒性至关重要.
- 氧化铁纳米粒子具有独特的磁性特性和生物相容性,可用于潜在的生物医学应用.
研究的目的:
- 设计Fe(3) O(4) 的多孔空心纳米颗粒 (PHNP),以有效地储存西斯和控制释放.
- 调查从PHNP中释放的西斯的pH响应释放机制.
- 评估Herceptin结合的,在乳腺癌细胞中含有西斯的PHNP的向输送和疗效.
主要方法:
- 通过受控的氧化和酸蚀刻制造Fe(3) O(4) PHNP.
- 在不同的pH条件下,PHNP毛孔大小和稳定性的特征.
- 在体外评估在生理和酸性pH下西斯丁释放动力学.
- 在SK-BR-3细胞上评估药物载荷PHNP与Herceptin结合的向细胞吸收和细胞毒性.
主要成果:
- (Fe) 3O 4PHNP已成功合成,其孔径方便了西斯普拉丁的加载.
- 在中性/基本pH下,西斯的释放缓慢 (t(1/2) = 16小时,但在酸性pH下 (<6) 显著加速 (t(1/2) <4小时).
- 与herceptin结合的phnps证明了与自由思柏 (IC(50) = 6.8 muM) 相比,对SK-BR-3乳腺癌细胞的增强向和有效性 (IC(50) = 2.9 muM).
结论:
- ((3) O ((4) PHNP 作为有效的载体,用于储存西斯和 pH 响应的释放.
- 低pH触发的加速释放机制对向癌症治疗具有前景.
- 这些PHNP代表了开发针对特定治疗应用的向药物输送系统的可行平台.
更多相关视频
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

